Universal Health Services Inc (UHS)

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Symbol: UHS
Exchange: NYSE
Sector: Healthcare
Industry: Medical Care Facilities
Market cap: $10.48B
52 week range: 140.08 - 246.33

Valuation

Share price: $175.72 (close of 2026-10-02)
P/E (TTM): 7.09x
Price to book: 1.38x
Price to free cash flow: 12.40x
Enterprise value: $15.61B
Book value per share: $127.09

Price performance

Period	Change
1 day	+0.37%
5 days	-1.76%
1 month	+4.91%
3 months	+10.98%
6 months	-0.55%
Year to date	-19.40%
1 year	-14.51%
3 years	+39.18%
5 years	+26.57%
10 years	+42.61%
All time	+13736.22%

Members of Congress who disclosed UHS trades

Alan Armstrong · Julia Letlow

Super investors holding UHS

First Eagle Investment (First Eagle Investment Management, LLC) · Richard Pzena (Pzena Investment Management) · Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates)

Profitability and growth

Return on equity: 20.29%
Return on invested capital: 12.40%
Return on assets: 9.59%
Return on capital employed: 16.23%
Gross margin: 11.48%
Net margin: 8.57%
EBITDA margin: 15.05%
Revenue growth: 9.71%
Net income growth: 30.36%
Free cash flow growth: -24.40%

Cash flow and balance sheet

Free cash flow yield (TTM): 8.06%
Current ratio: 1.12x
Net debt to EBITDA: 1.82x

Latest reported year

Period end: 2025-12-31
Fiscal year: 2025
Revenue: $17.36B
Cost of revenue: $15.37B
Gross profit: $1.99B
EBITDA: $2.61B
Net income: $1.49B
Earnings per share: $23.42
Interest expense: $156.07M
Shares outstanding: 63.58M

Income statement by year

Period end	Revenue	Gross profit	Net income	EPS
2025-12-31	$17.36B	$1.99B	$1.49B	$23.42
2024-12-31	$15.83B	$1.68B	$1.14B	$17.16
2023-12-31	$14.28B	$1.18B	$717.79M	$10.35
2022-12-31	$13.40B	$1.00B	$675.61M	$9.23
2021-12-31	$12.64B	$1.36B	$991.59M	$11.99
2020-12-31	$11.56B	$1.36B	$943.95M	$11.06
2019-12-31	$11.38B	$1.22B	$814.85M	$9.16
2018-12-31	$10.77B	$1.18B	$779.71M	$8.35
2017-12-31	$10.41B	$1.28B	$752.30M	$7.86
2016-12-31	$9.77B	$1.28B	$702.41M	$7.22

Margins and returns by year

Period end	Gross margin	Net margin	Return on equity	Return on capital
2025-12-31	11.48%	8.57%	20.29%	12.40%
2024-12-31	10.63%	7.22%	16.92%	11.63%
2023-12-31	8.23%	5.03%	11.58%	8.34%
2022-12-31	7.49%	5.04%	11.33%	7.13%
2021-12-31	10.78%	7.84%	16.01%	9.87%
2020-12-31	11.75%	8.17%	14.74%	11.24%
2019-12-31	10.69%	7.16%	14.61%	9.92%
2018-12-31	10.91%	7.24%	14.27%	10.03%
2017-12-31	12.30%	7.23%	14.89%	10.16%
2016-12-31	13.12%	7.19%	15.28%	10.03%

Cash and debt by year

Period end	Cash	Debt
2025-12-31	$137.80M	$4.00B
2024-12-31	$125.98M	$4.46B
2023-12-31	$119.44M	$4.79B
2022-12-31	$102.82M	$4.73B
2021-12-31	$115.30M	$4.14B
2020-12-31	$1.22B	$3.52B
2019-12-31	$61.27M	$3.90B
2018-12-31	$105.22M	$3.94B
2017-12-31	$74.42M	$3.49B
2016-12-31	$33.75M	$4.03B

Free cash flow by year

Period end	Free cash flow	Stock-based compensation
2025-12-31	$849.25M	$95.69M
2024-12-31	$1.12B	$99.35M
2023-12-31	$524.74M	$87.72M
2022-12-31	$262.02M	$85.38M
2021-12-31	$28.04M	$73.69M
2020-12-31	$1.63B	$65.84M
2019-12-31	$804.37M	$69.43M
2018-12-31	$609.78M	$66.58M
2017-12-31	$690.08M	$56.74M
2016-12-31	$813.90M	$48.11M

Dividend history

Most recent payment: 2026-09-01
Paid in the last twelve months: $0.80

Payment date	Dividend per share
2026-09-01	$0.20
2026-06-08	$0.20
2026-03-02	$0.20
2025-12-01	$0.20
2025-09-02	$0.20
2025-06-02	$0.20
2025-03-03	$0.20
2024-12-03	$0.20

Investor relations

Next earnings report

Next confirmed report: 2026-10-26
Consensus EPS estimate: $5.37

Past earnings dates

Reported	Fiscal period	EPS estimate
2026-07-27	Jun/2026	$5.66
2026-04-27	Mar/2026	$5.29
2026-02-25	Dec/2025	$5.92
2025-10-27	Sep/2025	$4.66
2025-07-28	Jun/2025	$4.85
2025-04-28	Mar/2025	$4.36
2025-02-26	Dec/2024	$4.19
2024-10-24	Sep/2024	$3.75

Filings and sources

Company website: uhs.com
SEC filings: 10-K, 10-Q and 8-K on EDGAR
Earnings calendar: All upcoming reports

Similar companies

DaVita Inc. (DVA) · HCA Healthcare, Inc. (HCA) · Abbott Laboratories (ABT) · Medtronic plc (MDT) · Stryker Corp (SYK) · Molina Healthcare, Inc. (MOH) · Boston Scientific Corp (BSX) · Centene Corp (CNC)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades